시장보고서
상품코드
1771492

세계의 바이러스 여과 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Virus Filtration Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments, Services), By Application (Biologicals, Medical Devices, Air Purification, Water Purification), By End-use, By Region, And Segment Forecasts, 2025 - 2030

발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 138 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

바이러스 여과 시장 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 바이러스 여과 시장 규모는 2025년부터 2030년까지 13.3%의 CAGR을 기록하며 2030년에는 114억 3,000만 달러에 달할 것으로 예상됩니다.

백신, 치료용 단백질, 혈액 및 혈액제제, 세포 및 유전자 치료제, 조직, 줄기세포 제품 등 생물학적 제제에 대한 수요 증가가 성장을 촉진하는 주요 요인입니다. 바이오의약품은 주로 인간, 동물, 식물에서 유래하기 때문에 제조 시 바이러스 오염을 피하기 위해 면밀한 바이러스 여과 절차가 필요합니다. 따라서 생물학적 제제 생산 시 이 절차가 필요하다는 점이 시장 성장을 촉진할 것으로 예상됩니다.

많은 대형 바이오 제약 및 생명공학 업체들은 혁신적인 생물학적 제제를 개발하기 위해 연구개발에 힘쓰고 있습니다. 예를 들어, 2016년 화이자는 연구개발에 78억 7,200만 달러를 투자했으며, 이는 2015년 대비 약 8% 증가한 수치입니다. 이 투자는 주로 지속가능한 백신 파이프라인과 유리한 상업적 기회를 가진 차별화 된 치료법을 달성하기 위해 연구 개발의 혁신과 생산성을 높이기 위해 이루어졌습니다. 바이러스 여과는 생물학적 제제 개발의 중요한 단계이기 때문에 생물학적 제제에 대한 연구 개발의 증가는 제품 수요를 촉진할 것으로 예상됩니다.

바이러스 여과 시장 : 분석 개요

  • 소모품 부문은 2024년 53.4%의 최대 매출 점유율로 바이러스 여과 시장을 장악했습니다. 장비 부문은 예측 기간 동안 12.9%의 CAGR로 크게 성장할 것으로 예상됩니다.
  • 생물학적 제제 부문은 2024년 가장 큰 매출 점유율로 바이러스 여과 시장을 장악했습니다. 의료기기 부문은 예측 기간 동안 크게 성장할 것으로 예상됩니다.
  • 바이오 제약 및 생명공학 기업은 2024년 가장 큰 매출 점유율로 바이러스 여과 시장을 이끌었으며, CRO(임상시험수탁기관) 부문은 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
  • 북미 바이러스 여과 시장은 2024년 42.6%의 가장 큰 매출 점유율을 차지하며 세계 시장을 장악했습니다. 미국의 바이러스 여과 시장은 2024년 가장 큰 매출 점유율로 북미 시장을 주도했습니다.
  • 아시아태평양의 바이러스 여과 시장은 예측 기간 동안 15.0%의 CAGR로 가장 빠르게 성장할 것으로 예상됩니다.

목차

제1장 분석 방법·범위

제2장 주요 요약

제3장 바이러스 여과 시장 : 변수, 동향, 범위

  • 시장 연관 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
  • 비즈니스 환경 분석
    • 업계 분석 : Porter's Five Forces 분석
    • PESTEL 분석

제4장 바이러스 여과 시장 : 제품별 비즈니스 분석

  • 시장 점유율 : 제품별(2024년·2030년)
  • 제품별 대시보드
  • 시장 규모 예측과 동향 분석 : 제품별(2018-2030년)
  • 소모품
  • 기기
  • 서비스

제5장 바이러스 여과 시장 : 용도별 비즈니스 분석

  • 시장 점유율 : 용도별(2024년·2030년)
  • 용도별 대시보드
  • 시장 규모 예측과 동향 분석 : 용도별(2018-2030년)
  • 생물학적 제제
  • 의료기기
  • 정수
  • 공기 정화

제6장 바이러스 여과 시장 : 최종 용도별 비즈니스 분석

  • 시장 점유율 : 최종 용도별(2024년·2030년)
  • 최종 용도별 대시보드
  • 시장 규모 예측과 동향 분석 : 최종 용도별(2018-2030년)
  • 바이오의약품·바이오테크놀러지 기업
  • CRO(의약품 임상시험수탁기관)
  • 의료기기 기업
  • 학술·연구기관

제7장 바이러스 여과 시장 : 지역별 추정·동향 분석

  • 시장 점유율 : 지역별(2024년·2030년)
  • 지역별 대시보드
  • 시장 규모 예측과 동향 분석(2018-2030년)
  • 북미
    • 국가별(2018-2030년)
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 국가별(2018-2030년)
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 덴마크
    • 스웨덴
    • 노르웨이
  • 아시아태평양
    • 국가별(2018-2030년)
    • 일본
    • 중국
    • 인도
    • 호주
    • 태국
    • 한국
  • 라틴아메리카
    • 국가별(2018-2030년)
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 국가별(2018-2030년)
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트
    • 쿠웨이트

제8장 경쟁 구도

  • 참여자 개요
  • 기업의 시장 포지션 분석
  • 기업 분류
  • 전략 매핑
  • 기업 개요/상장 기업
    • Merck KGaA
    • Danaher
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • GE HealthCare
    • Charles River Laboratories
    • Asahi Kasei Medical Co., Ltd.
    • WuXi AppTec
    • Lonza
    • Clean Biologics
ksm 25.07.24

Virus Filtration Market Growth & Trends:

The global virus filtration market size is expected to reach USD 11.43 billion by 2030, registering a CAGR of 13.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing demand for biological products such as vaccines, therapeutic proteins, blood and blood products, cellular and gene therapy, tissue, and stem cell products is a major factor driving the growth. Biopharmaceuticals are mainly derived from human, animal, and plants and therefore require a scrutinized virus filtration procedure to avoid virus contamination in the production. Therefore, the necessity of this procedure during the production of biologics is expected to boost the market growth.

Many leading biopharmaceuticals and biotechnology manufacturers are involved in R&D to develop innovative biological products. For instance, in 2016, Pfizer Inc. invested USD 7,872.0 million in R&D, which was around 8% more than the R&D investment in 2015. This investment was mainly made to boost innovation and productivity in R&D to accomplish a sustainable pipeline of vaccines and differentiated therapies with lucrative commercial opportunities. Virus filtration is an important step in biologics development, thus, increasing R&D on biologics is expected to drive the product demand.

Virus Filtration Market Report Highlights:

  • The consumables segment dominated the virus filtration market with the largest revenue share of 53.4% in 2024. The instruments segment is expected to grow at a significant CAGR of 12.9% over the forecast period.
  • The biologicals segment dominated the virus filtration market with the largest revenue share in 2024. The medical devices segment is expected to grow significantly over the forecast period.
  • The biopharmaceutical and biotechnology companies led the virus filtration market with the largest revenue share in 2024. The Contract Research Organizations (CRO) sector is expected to grow at the fastest CAGR over the forecast period.
  • The North America virus filtration market dominated the global market, accounting for the largest revenue share of 42.6% in 2024. The U.S. virus filtration market led the North American market with the largest revenue share in 2024.
  • The Asia Pacific virus filtration market is expected to grow at the fastest CAGR of 15.0% over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Virus Filtration Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Virus Filtration Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables Market, 2018 - 2030 (USD Million)
    • 4.4.2. Kits and reagents
      • 4.4.2.1. Kits and reagents Market, 2018 - 2030 (USD Million)
    • 4.4.3. Others
      • 4.4.3.1. Others Market, 2018 - 2030 (USD Million)
  • 4.5. Instruments
    • 4.5.1. Instruments Market, 2018 - 2030 (USD Million)
    • 4.5.2. Filtration Systems
      • 4.5.2.1. Filtration Systems Market, 2018 - 2030 (USD Million)
    • 4.5.3. Chromatography Systems
      • 4.5.3.1. Chromatography Systems Market, 2018 - 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Virus Filtration Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Biologicals
    • 5.4.1. Virus Filtration Market, in Biologicals, 2018 - 2030 (USD Million)
    • 5.4.2. Vaccines And Therapeutics
      • 5.4.2.1. Virus Filtration Market, in Vaccines and Therapeutics, 2018 - 2030 (USD Million)
    • 5.4.3. Blood And Blood Products
      • 5.4.3.1. Virus Filtration Market, in Blood And Blood Products, 2018 - 2030 (USD Million)
    • 5.4.4. Cellular And Gene Therapy Products
      • 5.4.4.1. Virus Filtration Market, in Cellular And Gene Therapy Products, 2018 - 2030 (USD Million)
    • 5.4.5. Tissue And Tissue Products
      • 5.4.5.1. Virus Filtration Market, in Tissue And Tissue Products, 2018 - 2030 (USD Million)
    • 5.4.6. Stem Cell Products
      • 5.4.6.1. Virus Filtration Market, in Stem Cell Products, 2018 - 2030 (USD Million)
  • 5.5. Medical Devices
    • 5.5.1. Virus Filtration Market, in Medical Devices, 2018 - 2030 (USD Million)
  • 5.6. Water Purification
    • 5.6.1. Virus Filtration Market, in Water Purification, 2018 - 2030 (USD Million)
  • 5.7. Air Purification
    • 5.7.1. Virus Filtration Market, in Air Purification, 2018 - 2030 (USD Million)

Chapter 6. Virus Filtration Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Biopharmaceutical & Biotechnology Companies
    • 6.4.1. Virus Filtration Market, in Biopharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
  • 6.5. Contract Research Organizations
    • 6.5.1. Virus Filtration Market, in Contract Research Organizations, 2018 - 2030 (USD Million)
  • 6.6. Medical Device Companies
    • 6.6.1. Virus Filtration Market, in Medical Device Companies, 2018 - 2030 (USD Million)
  • 6.7. Academic Institutes & Research Laboratories
    • 6.7.1. Virus Filtration Market, in Academic Institutes & Research Laboratories, 2018 - 2030 (USD Million)

Chapter 7. Virus Filtration Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Virus Filtration Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Virus Filtration Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. France Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. Italy Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Spain Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Denmark
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Denmark Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Sweden Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Norway Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Virus Filtration Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. Australia Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Thailand Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. South Korea
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. South Korea Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Virus Filtration Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Virus Filtration Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Merck KGaA
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Type Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Danaher
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Type Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Sartorius AG
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Type Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Thermo Fisher Scientific Inc.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Type Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. GE HealthCare
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Type Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Charles River Laboratories
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Type Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Asahi Kasei Medical Co., Ltd.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Type Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. WuXi AppTec
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Type Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Lonza
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Type Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Clean Biologics
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Type Benchmarking
      • 8.5.10.4. Strategic Initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제